eye treatment biosimilar
Scope
Date
~
-
Travel & Leisure
Lotte mulls Lotte World Tower spruce-up to rival Azabudai Hills Tower
Lotte Group is considering sprucing up the Lotte World Tower in Seoul, the tallest building in South Korea, to maintain its position as a landmark s...
Nov 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion applies for approval in Europe for eye treatment biosimilar
South Korean biopharmaceutical company Celltrion Inc. announced on Friday that it applied for approval from the European Medicines Agency (EMA) for ...
Nov 24, 2023 (Gmt+09:00)
-
Electronics
Samsung, LG lead global TV market in Q3 2023
Samsung Electronics Co. has retained the number one position in global TV market share, hitting a 30% mark in this year's third quarter, marking a p...
Nov 21, 2023 (Gmt+09:00)
-
Automobiles
Hyundai Motor Group eyes record-breaking sales in UK
Hyundai Motor Group expects to achieve record-high sales performance in the UK this year. This is even more significant because the UK is well well-...
Nov 20, 2023 (Gmt+09:00)
-
E-commerce
Alibaba continues eyeing S.Korean e-commerce M&A
Chinese tech giant Alibaba Group is seeking to purchase a major online retail platform in South Korea, one of the world’s largest e-commerce m...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
South Korean bio, pharma industry set to take leap
South Korea’s chemical maker LG Chem Ltd. is expected to reap more than 1 trillion won ($768.5 million) in sales this year from its new growth...
Nov 15, 2023 (Gmt+09:00)
-
Bio & Pharma
'World-class bispecific antibody technology of ABL Bio'
MADRID - "The clinical Phase 1 results of the immune-oncology candidate ABL111, developed in collaboration with ABL Bio, have been selected as the b...
Nov 13, 2023 (Gmt+09:00)
-
Bio & Pharma
SK Biopharma’s Cenobamate US patent extended by 2032
South Korea's SK Biopharmaceuticals announced on Friday an extension of its US patent for the epilepsy treatment Cenobamate, now set to expire on Oc...
Nov 10, 2023 (Gmt+09:00)
-
Electronics
LG Display’s OLED panel gets certifications for eye comfort
South Korea’s LG Display Co. announced on Wednesday its third-generation OLED TV panels got a certification from global safety science resea...
Nov 08, 2023 (Gmt+09:00)
-
Earnings
Celltrion enjoys record earnings on healthy biosimilar biz
South Korean pharmaceutical giant Celltrion Inc. logged record quarterly earnings on the strong performance of its key biosimilar products while exp...
Nov 07, 2023 (Gmt+09:00)
-
Artificial intelligence
SK Telecom invests in AI startups Allganize, Imprimed
SK Telecom Co. has invested a combined 9.4 billion won ($7.2 million) in artificial intelligence startups Allganize Inc. and Imprimed Inc., the top ...
Nov 06, 2023 (Gmt+09:00)
-
Bio & Pharma
Dong-A ST, UMass to jointly research for gene therapy
South Korea's Dong-A ST announced on Friday it has signed a joint research agreement with the University of Massachusetts (UMass) Chan Medical Schoo...
Nov 03, 2023 (Gmt+09:00)
-
Retail
E-Land eyes another leap forward in China under new strategy
SHANGHAI – E-Land World Ltd., a South Korean fashion and retail company, is gearing up for another leap forward in China, where the company&rs...
Oct 31, 2023 (Gmt+09:00)
-
Chemical Industry
Kumho Petrochem, POSCO look to carbon nanotube JV, share swap
South Korea’s Kumho Petrochemical Co. and POSCO International Corp. are considering launching a joint venture to produce carbon nanotubes (CNT...
Oct 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Biologics eyes new drugmaker acquisitions
BARCELONA -- Samsung Biologics Co., the world’s top contract manufacturing organization by capacity, is looking for acquisitions of new drugma...
Oct 27, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis gets FDA OK for its interchangeable biosimilar
Byooviz, a biosimilar of the macular degeneration treatment Lucentis and made by South Korea’s Samsung Bioepis, has received official design...
Oct 25, 2023 (Gmt+09:00)
-
ASK 2023
KIC eyes private debt, infrastructure in era of high interest rates
Sovereign wealth fund Korea Investment Corp. (KIC) is eyeing infrastructure and private debt in the era of higher-for-longer interest rates, while m...
Oct 25, 2023 (Gmt+09:00)
-
Bio & Pharma
VaxCell-Bio applies for approval of anti-cancer drug for dogs
South Korea’s VaxCell Biotherapeutics Co. (VaxCell-Bio) on Tuesday announced its application for approval for Vaxleukin-15, an anti-cancer dru...
Oct 24, 2023 (Gmt+09:00)
-
Energy
CS Wind eyes $2.2 bn sales in 2024 with Bladt
CS Wind Corp., a South Korean wind turbine tower manufacturer, expects its sales next year to double from last year’s to reach about 3 trillio...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Hanmi Pharma’s Phase 3 trials for anti-obesity medicine approved
South Korea’s Hanmi Pharmaceutical Co. on Monday said the Ministry of Food and Drug Safety approved Phase 3 clinical trials for the company&...
Oct 24, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion’s approved merger removes hurdle to three-way combination
South Korea’s biosimilar drugmaker Celltrion group on Monday moved one step closer to the planned combination of its three major affiliates wi...
Oct 23, 2023 (Gmt+09:00)
-
Bio & Pharma
Curocell to localize blood cancer drug by 2025
South Korean biotech company Curocell Inc. on Sunday said it will apply for approval from the Ministry of Food and Drug Safety in September next yea...
Oct 23, 2023 (Gmt+09:00)
-
Korean chipmakers
Samsung eyes next-generation 5 nm eMRAM auto chip by 2027
Samsung Electronics Co., the world’s largest memory chipmaker, said on Thursday it aims to develop a next-generation 5-nanometer-processed aut...
Oct 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Samsung Bioepis releases Soliris biosimilar in Europe
Samsung Bioepis Co., a biopharmaceutical research and development unit under South Korea's Samsung Group, is rolling out its latest product Epysqli,...
Oct 19, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare wins Remsima order in France, Italy
South Korea's Celltrion Healthcare Co. announced on Wednesday its autoimmune disease treatment Remsima (ingredient: infliximab) has won a bid for ho...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
Humedix gets gov't OK for trials of dementia candidate drug
South Korea’s Humedix Co., a developer of biological and pharmaceutical products, on Tuesday said it received approval from the Ministry of Fo...
Oct 18, 2023 (Gmt+09:00)
-
Bio & Pharma
GI Innovation transfers allergy treatment tech to Japan
South Korea's GI Innovation Inc. announced on Monday it has transferred its allergy treatment "GI-301" to the Japanese pharmaceutical company Maruho...
Oct 16, 2023 (Gmt+09:00)
-
Bio & Pharma
Celltrion Healthcare to supply Yuflyma to US pharmacy chain
South Korea's Celltrion Healthcare Co. has inked a deal with the US specialty pharmacy chain CarePartners Pharmacy to supply its autoimmune disease ...
Oct 16, 2023 (Gmt+09:00)
-
Bio & Pharma
S.Korean vaccine developer Quratis eyes Iraqi market
South Korean vaccine developer Quratis Inc. on Wednesday announced its signing of a term sheet on the direction and major transaction terms of coope...
Oct 12, 2023 (Gmt+09:00)
-
Korean food
Gluten-free Korean snack, pea soy sauce lure European gourmets
COLOGNE, Germany – The traditional Korean snack yakgwa and a soy-like sauce made with peas were named innovative foods of the year at the worl...
Oct 10, 2023 (Gmt+09:00)